Phase 2 Study to Assess the Safety and Efficacy of ANG003
for Exocrine Pancreatic Insufficiency (EPI)
26 locations incl. Long Beach
Sponsor: Anagram Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT07450547·Phase 2·Recruiting·Listed Mar 2026
Froedtert Hospital/Medical College of Wisconsin
Clinical research site in Milwaukee, Wisconsin · 9200 W WISCONSIN AVE, MILWAUKEE, WI 53226-3522 · (414) 805-6717 · Website
Part of Medical College of Wisconsin
As of July 2026, 70 paid clinical trials are recruiting at Froedtert Hospital/Medical College of Wisconsin in Milwaukee, Wisconsin. Active studies at this site cover conditions such as Pancreatic Cancer, Refractory Multiple Myeloma and Relapse Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Froedtert Hospital/Medical College of Wisconsin (70)
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
for Pulmonary Arterial Hypertension
15 locations incl. Scottsdale
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07218029·Phase 3·Recruiting·Listed Oct 2025
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
169 locations incl. Daphne
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for Neoplasms
77 locations incl. Birmingham
Sponsor: Celgene
Sex: All·Age: All ages
Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for Acute Myeloid Leukemia (AML)
42 locations incl. Gilbert
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
38 locations incl. Mobile
Sponsor: Incyte Corporation
Sex: Female·Age: 18 - 99
Code: NCT07023627·Phase 2·Recruiting·Listed Jun 2025
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for Pancreatic Neuroendocrine Tumor (pNET)
40 locations incl. Birmingham
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06943755·Phase 2, Phase 3·Recruiting·Listed Apr 2025
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for Advanced Breast Cancer
37 locations incl. Springdale
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06638307·Phase 1·Recruiting·Listed Oct 2024
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for Endometrial Adenocarcinoma
42 locations incl. Phoenix
Sponsor: Acrivon Therapeutics
Sex: Female·Age: 18+
Code: NCT05548296·Phase 2·Recruiting·Listed Sep 2022
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for Urothelial Carcinoma
144 locations incl. Gilbert
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04879329·Phase 2·Recruiting·Listed May 2021
DALY II USA/ MB-CART2019.1 for DLBCL
for Refractory Diffuse Large B Cell Lymphoma (DLBCL)
28 locations incl. Birmingham
Sponsor: Miltenyi Biomedicine GmbH
Sex: All·Age: 18+
Code: NCT04792489·Phase 2·Recruiting·Listed Mar 2021
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
for Acute Leukemia
23 locations incl. Duarte
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 2+
Code: NCT04811560·Phase 1, Phase 2·Recruiting·Listed Mar 2021
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for AML
36 locations incl. Gilbert
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06001788·Phase 1·Recruiting·Listed Aug 2023
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for Superficial Bladder Cancer
48 locations incl. Birmingham
Sponsor: enGene, Inc.
Sex: All·Age: 18+
Code: NCT04752722·Phase 1, Phase 2·Recruiting·Listed Feb 2021
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
for Prostate Cancer
30 locations incl. Birmingham
Sponsor: Janux Therapeutics
Sex: Male·Age: 18 - 100
Code: NCT05519449·Phase 1·Recruiting·Listed Aug 2022
US National OCS Heart Perfusion (OHP) Registry
for Heart Transplant
37 locations incl. Phoenix
Sponsor: TransMedics
Sex: All·Age: All ages
Code: NCT05915299·Recruiting·Listed Jun 2023
Impella RP Flex with Smart Assist
for Right Ventricular (RV) Dysfunction
31 locations incl. Birmingham
Sponsor: Abiomed Inc.
Sex: All·Age: All ages
Code: NCT06637644·Recruiting·Listed Oct 2024
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for Lymphoma, Non-Hodgkin's
21 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07226843·Phase 1·Recruiting·Listed Nov 2025
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
for Lymphoma, Non-Hodgkin
23 locations incl. Duarte
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07101328·Phase 1·Recruiting·Listed Aug 2025
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
for Neutropenia
22 locations incl. Phoenix
Sponsor: X4 Pharmaceuticals
Sex: All·Age: 12+
Code: NCT06056297·Phase 3·Recruiting·Listed Sep 2023
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
for Nasopharyngeal Cancer Recurrent
11 locations incl. Little Rock
Sponsor: Coherus Oncology, Inc.
Sex: All·Age: 12+
Code: NCT06457503·Phase 4·Recruiting·Listed Jun 2024
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for Neuroendocrine Tumors Unresectable
19 locations incl. Jacksonville
Sponsor: Perspective Therapeutics
Sex: All·Age: 18 - 90
Code: NCT05636618·Phase 1, Phase 2·Recruiting·Listed Dec 2022
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for Gastric Adenocarcinoma
10 locations incl. Orange
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT05365581·Phase 1·Recruiting·Listed May 2022
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
for Cholangiocarcinoma
8 locations incl. Los Angeles
Sponsor: Genfit
Sex: All·Age: 18+
Code: NCT05874414·Phase 1, Phase 2·Recruiting·Listed May 2023
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
for Ovarian Cancer
10 locations incl. Los Angeles
Sponsor: Nammi Therapeutics Inc
Sex: All·Age: 18+
Code: NCT06582017·Phase 1·Recruiting·Listed Sep 2024
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
for Myelodysplastic Syndromes
22 locations incl. Los Angeles
Sponsor: Taiho Oncology, Inc.
Sex: All·Age: 18+
Code: NCT04256317·Phase 2, Phase 3·Recruiting·Listed Feb 2020
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for Relapsed/Refractory Multiple Myeloma
7 locations incl. Palo Alto
Sponsor: Ichnos Sciences SA
Sex: All·Age: 18+
Code: NCT05862012·Phase 1·Recruiting·Listed May 2023
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA-2)
for AML
21 locations incl. Duarte
Sponsor: TScan Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05473910·Phase 1·Recruiting·Listed Jul 2022
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for Pancreatic Cancer Metastatic
9 locations incl. Fullerton
Sponsor: Panbela Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05254171·Phase 2, Phase 3·Recruiting·Listed Feb 2022
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
for Ischemic Stroke
14 locations incl. Downey
Sponsor: BrainQ Technologies Ltd.
Sex: All·Age: 22 - 80
Code: NCT06386874·Recruiting·Listed Apr 2024
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for Advanced Solid Tumor
13 locations incl. Los Angeles
Sponsor: Volastra Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05902988·Phase 1, Phase 2·Recruiting·Listed Jun 2023
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)
for Acute Myeloid Leukemia, in Relapse
13 locations incl. Gilbert
Sponsor: Oryzon Genomics S.A.
Sex: All·Age: 18+
Code: NCT05546580·Phase 1·Recruiting·Listed Sep 2022
A Study of ARC-02 in B-cell NHL
for B-cell Non Hodgkin Lymphoma
7 locations incl. Los Angeles
Sponsor: Taiho Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07691606·Phase 1·Recruiting·Listed Jul 9, 2026
US Zamto-cel Autoimmune Diseases
for Lupus Nephritis
1 location in Milwaukee
Sponsor: Miltenyi Biomedicine GmbH
Sex: All·Age: 18+
Code: NCT06708845·Phase 1·Recruiting·Listed Nov 2024
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
for Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer
4 locations incl. Atlanta
Sponsor: OncoTherapy Science, Inc.
Sex: All·Age: 18+
Code: NCT02926690·Phase 1·Recruiting·Listed Oct 2016
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
for Non Hodgkin Lymphoma
5 locations incl. Stanford
Sponsor: Miltenyi Biomedicine GmbH
Sex: All·Age: 18+
Code: NCT06116110·Recruiting·Listed Nov 2023
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
for Cystic Fibrosis (CF)
9 locations incl. La Jolla
Sponsor: Chris Goss
Sex: All·Age: 16+
Code: NCT07312734·Recruiting·Listed Dec 2025
MitoQ to Improve Vascular Funciton in Preeclampsia
for Preeclampsia
1 location in Milwaukee
Sponsor: Medical College of Wisconsin
Sex: Female·Age: 18 - 50
Code: NCT07229261·Recruiting·Listed Nov 2025
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
for Chronic Myeloid Leukemia, Chronic Phase
8 locations incl. Birmingham
Sponsor: University of Alabama at Birmingham
Sex: All·Age: 18+
Code: NCT05143840·Phase 2·Recruiting·Listed Dec 2021
Ivosidenib as Post-HSCT Maintenance for AML
for IDH1 Mutation
6 locations incl. Atlanta
Sponsor: Massachusetts General Hospital
Sex: All·Age: 18 - 75
Code: NCT06707493·Phase 2·Recruiting·Listed Nov 2024
Showing the 40 most relevant of 70 recruiting trials at this site. Browse all with filters →
More research sites in Milwaukee
- Medical College of Wisconsin (245 trials)
- Aurora Sinai Medical Center (50 trials)
- Aurora Saint Luke's Medical Center (48 trials)
- Aurora Cancer Care-Milwaukee (46 trials)
- Children's Hospital of Wisconsin (44 trials)
- Froedtert & the Medical College of Wisconsin (21 trials)
- Children's Wisconsin (21 trials)
- Froedtert Hospital & the Medical College of Wisconsin (18 trials)
- Froedtert Hospital and the Medical College of Wisconsin (17 trials)
- Aurora St. Luke's Medical Center (15 trials)
Explore more
Paid clinical trials in Milwaukee, WI · Wisconsin clinical trials